IL130925A0 - Arginine silicate inositol complex and use thereof - Google Patents
Arginine silicate inositol complex and use thereofInfo
- Publication number
- IL130925A0 IL130925A0 IL13092598A IL13092598A IL130925A0 IL 130925 A0 IL130925 A0 IL 130925A0 IL 13092598 A IL13092598 A IL 13092598A IL 13092598 A IL13092598 A IL 13092598A IL 130925 A0 IL130925 A0 IL 130925A0
- Authority
- IL
- Israel
- Prior art keywords
- pct
- arginine silicate
- inositol complex
- silicate inositol
- sec
- Prior art date
Links
- 239000004475 Arginine Substances 0.000 title 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 title 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 title 1
- 229960000367 inositol Drugs 0.000 title 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/04—Esters of silicic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/799,784 US5707970A (en) | 1997-02-12 | 1997-02-12 | Arginine silicate complex and use thereof |
| PCT/US1998/002443 WO1998034647A1 (en) | 1997-02-12 | 1998-02-11 | Arginine silicate inositol complex and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL130925A0 true IL130925A0 (en) | 2001-01-28 |
Family
ID=25176739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13092598A IL130925A0 (en) | 1997-02-12 | 1998-02-11 | Arginine silicate inositol complex and use thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US5707970A (de) |
| EP (1) | EP1007096B1 (de) |
| JP (1) | JP2001512443A (de) |
| KR (1) | KR20000070977A (de) |
| CN (1) | CN1182873C (de) |
| AT (1) | ATE251914T1 (de) |
| AU (1) | AU722975B2 (de) |
| BR (1) | BR9807675A (de) |
| CA (1) | CA2279233A1 (de) |
| DE (1) | DE69819016T2 (de) |
| DK (1) | DK1007096T3 (de) |
| ES (1) | ES2209112T3 (de) |
| HU (1) | HUP0001998A3 (de) |
| IL (1) | IL130925A0 (de) |
| PT (1) | PT1007096E (de) |
| WO (1) | WO1998034647A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5707970A (en) | 1997-02-12 | 1998-01-13 | Nutrition 21 | Arginine silicate complex and use thereof |
| US20020068365A1 (en) * | 1998-07-28 | 2002-06-06 | Eric H. Kuhrts | Controlled release nitric oxide producing agents |
| WO2002008175A2 (en) * | 2000-07-24 | 2002-01-31 | Nutrition 21, Inc. | Arginine saccharate and use thereof |
| US6552074B2 (en) * | 2000-11-16 | 2003-04-22 | Fukumi Morishige | Arginine/ascorbic acid mixed powder as an oral supplement |
| TWI283427B (en) * | 2001-07-12 | 2007-07-01 | Semiconductor Energy Lab | Display device using electron source elements and method of driving same |
| WO2003053288A1 (en) * | 2001-12-20 | 2003-07-03 | Trivascular, Inc. | Advanced endovascular graft |
| US7147661B2 (en) * | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
| EP1534302A4 (de) * | 2002-08-22 | 2009-01-07 | Nutrition 21 Inc | Argininsilikat/inositol-komplex und seine verwendung |
| US6803456B1 (en) * | 2003-08-13 | 2004-10-12 | Rutherford Chemicals Llc | Process for the production of arginine-silicate complex |
| US7803178B2 (en) * | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
| US20050228484A1 (en) * | 2004-03-11 | 2005-10-13 | Trivascular, Inc. | Modular endovascular graft |
| WO2006129353A1 (ja) * | 2005-06-01 | 2006-12-07 | Coral Biotech Kabushiki Kaisha | 新規な血圧上昇抑制剤 |
| ITMI20060677A1 (it) * | 2006-04-06 | 2007-10-07 | Damor Farmaceutici | Profarmaci dell'arginina ad elevata attivita'terapeutica |
| EP2070541A4 (de) * | 2006-09-21 | 2011-04-13 | Toshiki Oguro | Mittel zur förderung der regeneration von hartem gewebe |
| EP2134351B1 (de) | 2007-03-13 | 2016-04-27 | Nutrition 21, Inc. | Verfahren und zusammensetzungen zur verzögerten freisetzung von chrom |
| WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
| GB0805279D0 (en) * | 2008-03-20 | 2008-04-30 | Univ Nottingham Trent | Food supplement |
| WO2012035364A1 (en) | 2010-09-15 | 2012-03-22 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid, its preparation and use |
| WO2012119007A1 (en) | 2011-03-01 | 2012-09-07 | N21 Acquisition Holding, Llc | Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders |
| US11191735B2 (en) | 2015-03-13 | 2021-12-07 | Nutrition 21, Llc | Arginine silicate for periodontal disease |
| GB2557471A (en) * | 2015-06-30 | 2018-06-20 | Jds Therapeutics Llc | Arginine silicate inositol for improving cognitive function |
| US10703608B2 (en) | 2015-07-13 | 2020-07-07 | Otis Elevator Company | Deterrent device inhibition key |
| US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
| CN109069532A (zh) | 2016-02-11 | 2018-12-21 | 营养21有限责任公司 | 含铬组合物用于改善健康和健身 |
| JP2019526638A (ja) | 2016-09-01 | 2019-09-19 | ジェイディーエス・セラピューティクス、エルエルシー | ビオチン酸マグネシウム組成物および使用方法 |
| CN113329680A (zh) | 2018-11-02 | 2021-08-31 | 营养21有限责任公司 | 用于改善视频游戏者认知功能的含有肌醇稳定的精氨酸硅酸盐复合物和肌醇的组合物 |
| EP4076413A1 (de) | 2019-12-16 | 2022-10-26 | Nutrition 21, LLC | Verfahren zur herstellung von arginin-silikat-komplexen |
| WO2023086567A1 (en) * | 2021-11-12 | 2023-05-19 | Nutrition21, LLC | Compositions and methods for treating or preventing myopathy in poultry |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3337403A (en) * | 1963-09-05 | 1967-08-22 | Hoffmann La Roche | Stable and palatable pharmaceutical compositions |
| US4297349A (en) * | 1980-04-15 | 1981-10-27 | Sandoz, Inc. | Silicon-bearing carboxylic acids and amides |
| US4385052A (en) * | 1981-07-20 | 1983-05-24 | International Plant Research Institute, Inc. | Use of trialkylsilyl-6-aminonicotinamides for the treatment of psoriasis |
| FR2610522B1 (fr) * | 1987-02-06 | 1989-08-18 | Gueyne Jean | Produit therapeutique a base de derives organiques du silicium |
| US5250569A (en) * | 1991-04-22 | 1993-10-05 | Godfrey Science & Design, Inc. | Amino acid flavorings of aluminum astringent for oral use |
| US5622980A (en) * | 1993-08-17 | 1997-04-22 | Applied Analytical Industries, Inc. | Oral compositions of H2-antagonists |
| FR2745498A1 (fr) * | 1996-02-29 | 1997-09-05 | Giroux Jean Marc | Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite |
| US5707970A (en) * | 1997-02-12 | 1998-01-13 | Nutrition 21 | Arginine silicate complex and use thereof |
-
1997
- 1997-02-12 US US08/799,784 patent/US5707970A/en not_active Expired - Lifetime
-
1998
- 1998-02-11 CN CNB988023695A patent/CN1182873C/zh not_active Expired - Fee Related
- 1998-02-11 EP EP98905010A patent/EP1007096B1/de not_active Expired - Lifetime
- 1998-02-11 CA CA002279233A patent/CA2279233A1/en not_active Abandoned
- 1998-02-11 KR KR1019997007243A patent/KR20000070977A/ko not_active Application Discontinuation
- 1998-02-11 AT AT98905010T patent/ATE251914T1/de not_active IP Right Cessation
- 1998-02-11 DK DK98905010T patent/DK1007096T3/da active
- 1998-02-11 BR BR9807675-2A patent/BR9807675A/pt not_active Application Discontinuation
- 1998-02-11 DE DE69819016T patent/DE69819016T2/de not_active Expired - Fee Related
- 1998-02-11 WO PCT/US1998/002443 patent/WO1998034647A1/en active IP Right Grant
- 1998-02-11 PT PT98905010T patent/PT1007096E/pt unknown
- 1998-02-11 HU HU0001998A patent/HUP0001998A3/hu unknown
- 1998-02-11 ES ES98905010T patent/ES2209112T3/es not_active Expired - Lifetime
- 1998-02-11 JP JP53496698A patent/JP2001512443A/ja not_active Ceased
- 1998-02-11 IL IL13092598A patent/IL130925A0/xx unknown
- 1998-02-11 US US09/367,267 patent/US6156735A/en not_active Expired - Lifetime
- 1998-02-11 AU AU62737/98A patent/AU722975B2/en not_active Ceased
-
2000
- 2000-12-05 US US09/730,895 patent/US6344444B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69819016D1 (de) | 2003-11-20 |
| CN1246801A (zh) | 2000-03-08 |
| WO1998034647A1 (en) | 1998-08-13 |
| DK1007096T3 (da) | 2003-12-01 |
| CN1182873C (zh) | 2005-01-05 |
| ATE251914T1 (de) | 2003-11-15 |
| BR9807675A (pt) | 2000-02-15 |
| AU6273798A (en) | 1998-08-26 |
| US6344444B1 (en) | 2002-02-05 |
| HUP0001998A2 (hu) | 2000-10-28 |
| HUP0001998A3 (en) | 2002-01-28 |
| PT1007096E (pt) | 2004-03-31 |
| JP2001512443A (ja) | 2001-08-21 |
| DE69819016T2 (de) | 2004-04-29 |
| CA2279233A1 (en) | 1998-08-13 |
| KR20000070977A (ko) | 2000-11-25 |
| EP1007096A1 (de) | 2000-06-14 |
| AU722975B2 (en) | 2000-08-17 |
| US5707970A (en) | 1998-01-13 |
| ES2209112T3 (es) | 2004-06-16 |
| EP1007096B1 (de) | 2003-10-15 |
| US6156735A (en) | 2000-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL130925A0 (en) | Arginine silicate inositol complex and use thereof | |
| FI972164A (fi) | Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö | |
| BG103793A (en) | COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS | |
| AU1694392A (en) | Determination of motifs of peptides on mhc molecules | |
| IL113566A0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration | |
| IL110943A (en) | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders | |
| PL340561A1 (en) | Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders | |
| IL126296A0 (en) | Benzopyran derivatives having leukotriene antagonistic action | |
| AU8974298A (en) | 1,4,7,10-tetraazabicyclo{8.2.2}tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles | |
| GB9712966D0 (en) | Novel chalcones | |
| MX9703944A (es) | Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis. | |
| BG105275A (en) | Tan-1057 derivatives | |
| IL137668A0 (en) | Method and device for extracting plant ingredients | |
| WO2000038620A3 (en) | A composition useful to treat periodontal disease | |
| MD670G2 (ro) | Remediu cu acţiune imunomodulatoare | |
| IL130347A0 (en) | Process for reducing sulfur and vat dyes | |
| ES2163001T3 (es) | Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica. | |
| MD1473G2 (ro) | Remediu antiherpetic | |
| ATE251368T1 (de) | Verfahren und vorrichtung zur reduzierung des leistungsverbrauchs in einem öffentlichem fernsprechgerät | |
| SI0801639T1 (en) | Method for preparing substituted anthraquinones and use thereof for preparing rheins | |
| DE59702821D1 (en) | Dimethyl-substituierte cyclohexandienderivate | |
| FR2716339B1 (fr) | Dispositif d'accrochage de produits en grappes tels que des jambons. | |
| AU1481902A (en) | Decontamination of animal feed containing prion (eg. BSE agent). | |
| AU5269696A (en) | Anellated beta-carbolines | |
| UA26940C2 (uk) | Засіб для визhачеhhя супресорhої лаhки імуhhого статусу людиhи та спосіб визhачеhhя супресорhої лаhки імуhhого статусу людиhи |